6 studies were found.

1.		Recruiting	STA-4783 and Paclitaxel for Treatment of Solid Tumors Condition: Neoplasms
2.		Recruiting	STA-4783 in Combination with Paclitaxel and Carboplatin for the Treatment of Chemotherapy Naive Patients with Stage IIIB/IV Non Small Cell Lung Cancer (NSCLC) Conditions: stage IIIB non-small cell lung cancer; stage IV non-small cell lung cancer
3.		Recruiting	STA-4783/Paclitaxel or Paclitaxel Alone in Melanoma Condition: Melanoma
4.		Recruiting	STA-5312 Administered on Alternate Weekdays Every Two Weeks to Patients with Hematologic Malignancies Conditions: Hematological Malignancies; Leukemia; Lymphoma
5.		Recruiting	STA-5326 in Crohn's Disease Patients Condition: Crohn's Disease
6.		Recruiting	A Study of STA-4783 in Combination with Weekly Paclitaxel for Treatment of Patients with Soft Tissue Sarcomas Condition: Soft Tissue Sarcoma